• Medical_Professionals
• Medical_students
• Nurses

Dear Friends and Colleagues,

The Brazilian Society of Anesthesiology is honored to organize the 16th International Congress of Cardiovascular Anesthesia (ICCVA), exploring topics of great relevance to the scientific community. Experts of international renown will give lectures on the state of the art in the field and workshops will be available for the development of essential skills. We are pleased and honored to invite you to participate. The meeting will be held at the Windsor Oceânico, a hotel complex by the sea in the neighborhood of Barra da Tijuca, Rio de Janeiro.

Andrew Klein

UK

Andrew Shaw

USA

Benjamin Drenger

Israel

Burkhard Mackensen

USA

Chirojit Mukherjee

Germany

Christopher Troianos

USA

Daniel BainbridgeCanada

Daniel Bainbridge

Canada

Daniel Bolliger

Switzerland

Dawn Desiderio

USA

David Mazer

Canada

David Scott

Australia

Davy Cheng

Canada

BRL

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Windsor Barra Hotel

Avenida Lúcio CostaBarra da Tijuca

Barra Da Tijuca, Rio De Janeiro, Brazil

Submission Info

The abstract submission site will open on February, 2017 and will close on May 30, 2017

Additional abstract submissions will not be accepted after the submission system closes. Please make sure you receive email confirmation of your abstract submission before the abstract submission site’s closing date and time. If you do not receive email confirmation of your abstract submission, please send an e-mail to abstractbrasil@mci-group.com. Once you submit your abstract via the submission site, you will not be able to further revise your abstract.

Submissions will be made to one of the following categories:

1. Basic Science

2. Cardiac Anesthesia

3. Case Reports

4. Coagulation, Bleeding and Transfusion

5. Echocardiography

6. Intensive Care Medicine

7. Perioperative Medicine

8. Thoracic Anesthesia

9. Vascular Anesthesia

10. Congenital Heart Disease

Instructions for Online Abstract Submissions:

1. Abstracts are limited to 3300 characters (including spaces). This includes abstract title, abstract text and any additional tables or other graphics.

2. Title characters are included in overall character count. The abstract title should be short and specific to the main topic presented in the abstract. Please do not use abbreviations in the title. Capitalize first letter of each word in the title. Do not enter the title information in all upper case letters or in quotation marks.

3. Tables or other graphics may only be submitted as still images (No video clips). These should be submitted in the field of the abstract. No video loops and images will be accepted. However, if a presenter wishes to show a vídeo loop, he/she is welcome to display that loop at their poster on a personal laptop or tablet.

4. The abstract should be single spaced.

5. Review of abstract submissions is blinded. Please do not include names of abstract authors or institutions in the abstract and do not include references, credits or grant support in the body of the abstract that can be used to identify the authors or institutions responsible for the abstract. There is an additional section in the abstract submission process where you will input references and also input grant and industry support. This information will be linked to your abstract after the blinded review process is completed.

6. Abstracts should include four sections: Background, Methods, Results and Conclusions. The Background section should clearly state the study hypothesis. Methods and Results should be stated in sufficient detail to support conclusions.

7. The submitting author must submit disclosure of all conflicts of interest related to content of research abstract or otherwise state that the author has no conflict of interest.

8. The submitting author must confirm that submitted research was approved by the submitting institution’s research review board (IRB) and that informed consent/assent was obtained from each subject and/or parent or guardian, or waiver of consent was granted by the IRB. Institutional quality improvement committee approval is not sufficient without also having IRB approval or a written statement from the IRB that the study is IRB exempt.

9. Please use generic drug/product names rather than trade names.

10. Standard abbreviations may be used without definition. Non-standard abbreviations (kept to a minimum) should be placed in parentheses after the first use of the corresponding word or phrase abbreviated.

Abstract Review Criteria:

1. Background: Clearly stated study hypothesis. If a case report or case series, the reason for presenting the case(s) is clearly stated instead of a study hypothesis.

2. Methods: Clearly described. The authors state the method of data collection (e.g.) prospective data collection or chart review. If statistical methodology is indicated, these methodologies are clearly described.

3. Results: Presented in a manner (description +/- graphics) that is easy for the reader to understand. For case presentations, the appropriate clinical details are included. Descriptive and statistical results are stated.

4. Conclusion: Well stated so that it is obvious how the data support or refute the stated hypothesis. Case report conclusions should clearly state how observations support a clinical or scientific principle or hypothesis worthy of future study.

5. Clarity of presentation: Well written in a style that is understandable to a non- specialist. The “message” is easily understood by the reader without having to re-read the abstract several times.

Additional Information Regarding Abstract Submissions:

1. Abstracts must summarize an original contribution and may not be presented at another medical meeting prior to presentation at the 16th ICCVA. The abstract authors attest that the material has not been presented or published elsewhere and will not be presented or published elsewhere prior to presentation at the Congress. If there is any question regarding similarity to earlier work or possible duplication or redundancy, it is the responsibility of the submitting abstract author to consult the Committee of the Congress trough the e-mail abstractbrasil@mci-group.com. Additionally, if there is a potential conflict regarding an abstract already being presented or published, please notify us of the potential conflict at the time of submission by e-mail. Failure to comply will result in the abstract being rejected.

2. Abstracts chosen for presentation are selected strictly by blinded peer-review criteria.

3. Only abstracts submitted using the online submission system will be considered for presentation.

4. Only authors (and not their assistants) may complete submissions. The submitting authors will be responsible for the abstract information provided.

5. The submitting author will attest that all co-authors of the abstract have granted consent for the material to be submitted for presentation, and that the submitting author has been granted the right by all co-authors to act on their behalf.

6. The submitting author must be registred in 16th ICCVA to be able to submit the abstract.

7. All abstracts must be submitted in English, Spanish or Portuguese.

8. An abstract may only be submitted once i.e. the abstract may not be submitted under multiple submission categories.

9. The presenting author for each abstract must attend the 16th ICCVA. In the event that a change of presenting author must be made after the submission of the abstract, the Committe must be notified in writing as soon as possible. The replacement presenter must be a co-author of the abstract.

10. The Committe will not edit abstracts. Please edit abstract for grammar and syntax prior to submission. Submitted abstracts are final versions and additional changes including adding or changing authors will not be permitted.

11. No abstract will be considered with deferred outcome data. If data are to be presented, they must appear in the original abstract submitted.

12. Abstract submissions should include the best available evidence and should not include content that is biased or promotional in nature.

13. If submitting multiple abstracts, disclosures must be completed for EACH SEPARATE SUBMISSION. Disclosures are assessed for each individual topic. If any author fails to submit his/her disclosures, the abstract will not be reviewed and will be rejected.

Notifications:

Submitters will be notified in June 2017 regarding acceptance of their abstract. Please note, presenting an abstract does NOT provide you with complimentary registration to attend the 16th ICCVA.

Carolina Pinheiro

MCI Brasil  : +55 (21) 2286 2846

iccva2017@mci-group.com

Contact No.: (855) 658-2828

Email: info@scahq.org